Low expression of BAZ2B may promote breast cancer progression by reshaping tumour metabolism. Read on to learn more.
The team studied a total of 3,79,944 participants without cardiovascular disease at baseline, including 65,047 individuals ...
ELF3 axis enables luminal progenitor transformation in BRCA1-deficient breast cancer by reducing genomic instability and promoting progenitor identity.